New Key Statistics Module, Z-Score and F-Score
NAS:VNDA Key Ratios
| Market Cap $ M | 268.22 |
| Enterprise Value $ M | -100.10 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 22.66 |
| Price/Book | 0.50 |
| Price/Sales | 1.40 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 190.00 |
| EPS (TTM) $ | -0.28 |
| Beneish M-Score | -1.79 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -1,465.80 |
| EV-to-EBIT | 2.67 |
| EV-to-EBITDA | 3.32 |
| PEG | -- |
| Shares Outstanding M | 58.31 |
| Net Margin (%) | -8.59 |
| Operating Margin % | -19.64 |
| Pre-tax Margin (%) | -9.48 |
| Quick Ratio | 4.84 |
| Current Ratio | 4.85 |
| ROA % (ttm) | -2.53 |
| ROE % (ttm) | -3.02 |
| ROIC % (ttm) | -13.51 |
| Dividend Yield % | -- |
| Altman Z-Score | 2.02 |
VNDA Number of Guru Trades
VNDA Volume of Guru Trades
Gurus Latest Trades with NAS:VNDA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:VNDA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Vanda Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:VNDA
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers